Overview

Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

Status:
Completed

Trial end date:
2017-12-28

Target enrollment:

Participant gender:

Summary

The main purpose is to establish the equivalence of Triferic iron administered via dialysate into the arterial blood line and into the venous blood line

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Rockwell Medical Technologies, Inc.

Treatments:

Citric Acid
Hemodialysis Solutions
Iron